Trial Profile
A Phase II Study of Perifosine in Soft Tissue Sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2013
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 02 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2005 New trial record.